Table of Contents
<< Previous Issue | Apr 2014 (Vol: 2014, Issue: 4) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Horizon Pharma Looks to Tax Efficiency with Acquisition of Ireland’s Vidara Therapeutics
-
Baxter Follows Abbott’s Lead with Plan to Split into Two Independent Companies
- Section: Research & Development
-
BMS Expands Immuno-Oncology Pipeline with Five Prime Partnership
-
Celgene Gains Option to Buy Partner Forma Therapeutics via US$600 M Multistage Collaboration